Introduction Early Access Programs (EAPs) help to give people with life threatening or seriously deb...
Read moreIntroduction On 1 July 2021, France made changes to its long-standing Authorization for Temporary Us...
Read moreIntroduction Following Brexit, regulatory oversight in the UK has switched from the European Medicin...
Read moreThe study, compiled by IQVIA, covers 160 drugs, including 41 oncology drugs and 57 orphan drugs whic...
Read moreIntroduction Early Access Programs, also known as special access programs, give patients access to m...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe report looks at how differences in cancer survival rates between the UK and other countries have...
Read moreThe draft final guidance reverses previous guidance issued in November 2021 rejecting the drug for r...
Read morePatients in England will be the first in Europe to have access to Takeda’s Exkivity (mobocertinib)...
Read moreAmgen’s Lumykras (sotorasib) has become the first active new technology to come through the Innova...
Read more